SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                                    FORM 8-K


                Current Report Pursuant to Section 13 or 15(d) of
                           the Securities Act of 1934


     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


         Date of Report (Date of earliest event reported) April 30, 2002

                              ---------------------



                        PACIFICHEALTH LABORATORIES, INC.
                        --------------------------------
             (Exact name of registrant as specified in its charter)

          Delaware                   000-23495               22-3367588
          --------                   ---------               ----------
(State or other jurisdiction        (Commission             (IRS Employer
      of Incorporation)             File Number)          Identification No.)


      1480 Route 9 North, Suite 204, Woodbridge, New Jersey         07095
      -----------------------------------------------------         -----
             (Address of principal executive offices)             (Zip Code)


         Registrant's telephone number, including area code 732/636-6141
         ---------------------------------------------------------------
          (Former name or former address, if changed since last report)







Item 5. Other Items.

I.   Appointment of New Director

     Effective April 30, 2002, PacificHealth Laboratories, Inc. (the "Company")
increased the size of its Board of Directors from six to seven and elected
Joseph Harris as a director of the Company to fill the vacancy thus created. Mr.
Harris is currently Senior Vice-President - Corporate Development of Cantel
Medical Corporation, a Nasdaq-listed medical device company. From 1996 to 2000,
he was a Senior Vice-President and Director - Corporate Strategy and Development
for SmithKline Beecham plc, a major pharmaceutical and healthcare company listed
on both the New York Stock Exchange and London Stock Exchange. From 1988 to
1996, Mr. Harris served as Managing Director - Business Development and
Director-Licensing and Technology Development for Eastman Kodak Company. He has
also served as General Counsel, Secretary and Treasurer for Acme Electric
Corporation, a New York Stock Exchange company that manufactures electrical and
electronic equipment. Mr. Harris is licensed to practice law and is a certified
public accountant in New York. In these capacities, he has worked as an attorney
for Mackenzie Lewis Michelle & Hughes, a Syracuse, New York law firm and as an
accountant on the tax and audit staff for Coopers & Lybrand, an International
Public Accounting Firm based in Syracuse, New York.


                                   SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                     PACIFICHEALTH LABORATORIES, INC.

Dated: May 2, 2002                   By: /s/ Robert Portman
                                     ----------------------
                                     Robert Portman, President